In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts.
A. Benedict Cosimi(Harvard University), Robert B. Colvin(Harvard University), D Conti(Azienda Usl Toscana Centro), Ronald B. Faanes(Massachusetts General Hospital), Robert Rothlein(Thomas Jefferson University), S L Wee(Harvard University), F I Preffer(Harvard University), F L Delmonico(Harvard University)
Cited by 371
Related Papers
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
|American Journal of Transplantation|2008|1.9k
Reactivity of a monoclonal antibody with human ovarian carcinoma.
|Journal of Clinical Investigation|1981|1.7k
International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology
|Kidney International|1993|1.5k
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
|American Journal of Transplantation|2014|1.3k